_id
6910522bccc777a4e85d54a9
Ticker
CNSP
Name
CNS Pharmaceuticals Inc
Exchange
NASDAQ
Address
2100 West Loop South, Houston, TX, United States, 77027
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.cnspharma.com
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Last Close
5.52
Volume
16420
Current Price
5.2813
Change
-0.21
Last Updated
2026-01-02T11:44:08.329Z
Image
data:image/webp;base64,UklGRh4DAABXRUJQVlA4IBIDAACwEQCdASpAAEAAPqlEmkmmI6KhM/gNUMAVCWwAxbuTfD8PtxoRM51fiRdMDzAeAB2AH+I6gD0AOky8muK8GJNgQY0rSGo+RcDhiZaljNZvEEmXnCB6fq7GqmbU1xwh14pJWXtCCtR59dfPCvhblM4ZMXe7EOcyi1lN+maR5AuKvEUh4ygp1ITmw5UAD86BZSnoGsPJAAAA/vvZHcBlou3qvf4bmHRTV/FVK3f9eAH9ub+eYDuaCnCB+iyKXmzfgreacbapRjRj8m7IAihoS6IzbnOinIMScSIOEFW3BduCe5273fuE+qk9cJbRr8enYvAiG+zR3qgL1lGTWsZJKGpmIo0naZBENlHB7XqWaInYRZwGNnRfQkv/oBTApkTggKDPU0e2s6i80qH2m8KRWrVRa9xa1RUF/QdCm7gKm3t1p6gD8DM1WCupx+X1dqN3M2W2bvkRVbiM7+7trR/Ei39nCHpoYbdyFwmVFuW+FyUL9N2IHWlr+prXJtCGj4XgR9d0ICfXPQINBCxd7nGulap+T/JAEfvDfpuTtINl6AHL39ntK9T2RxIF4pCufEhYI3fBKeozDnVhe2rjUVVvyWdl3sEnfQ9w1SpLVbAmCqc4RCpft+ynDknLOlDt9VCZRldJetgs87VXz88Nvm+mTSJxkbx0LBlrVLs3hv+eXCVwlm0Z/2s7l9+n12+tj0nr8V76hsFa005yyIn8C+8oEkJhkAs2QmEdO9x90+n+3FptW3Z0mVPbxhN32sO5h2xR7o1FbKLxBlzsJ9xI2L5LW4pZT4taSndjq9k8OcyuXCBDGgY2rlavcbnt6O4s56FGzTmAB3lnmraDUX6jKnHJCuRgSK/0limi5XCaPJjJaRMsoBd9Qi6p9eqV5PCeo3JaOPfEd4nvaTaQYM1gggrxf8nkd1ZTLvLkx4Ae4SpqvpNTXrJGHlqhz+ZQLSppCXFOfzKz/orHIXJkOsksF9zOtyeKRQIh/ypXGtjy8mL3IcU6FBUGZNI+wkTQwY9sHIXLV3a8fBA+YjvOqugc/cnuI+SEAAA=
Ipo Date
2019-11-08T00:00:00.000Z
Market Cap
3016550
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Target Price
20
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
697
Gross Profit
-697
Operating Expenses
3252691
Operating Income
-3253388
Interest Expense
2116
Pretax Income
-3218481
Net Income
-3218481
Eps
-104.3504522906332
Dividends Per Share
-
Shares Outstanding
574580
Income Tax Expense
-
EBITDA
-3215668
Operating Margin
-
Total Other Income Expense Net
34907
Cash
9864087
Short Term Investments
-
Receivables
0
Inventories
-
Total Current Assets
11391735
Property Plant Equipment
3107
Total Assets
11869258
Payables
1928324
Short Term Debt
30793
Long Term Debt
-
Total Liabilities
1959117
Equity
9910141
Bs_currency_symbol
USD
Depreciation
697
Change In Working Capital
1025161
Cash From Operations
-2174170
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-91616
Net Change In Cash
-2265786
Cf_currency_symbol
USD
PE
0.0068
PB
0.0164368131492781
ROE
-32.476641856054314
ROA
-27.11610953271047
FCF
-2174170
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
9
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
4.5
Net Net Investing Score
8
Quality Investing Score
2.5
Value Investing Score
7.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
697
Quarters > 0 > income Statement > gross Profit
-697
Quarters > 0 > income Statement > operating Expenses
3252691
Quarters > 0 > income Statement > operating Income
-3253388
Quarters > 0 > income Statement > interest Expense
2116
Quarters > 0 > income Statement > pretax Income
-3218481
Quarters > 0 > income Statement > net Income
-3218481
Quarters > 0 > income Statement > eps
-104.3504522906332
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
30843
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3215668
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
34907
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
9864087
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11391735
Quarters > 0 > balance Sheet > property Plant Equipment
3107
Quarters > 0 > balance Sheet > total Assets
11869258
Quarters > 0 > balance Sheet > payables
1928324
Quarters > 0 > balance Sheet > short Term Debt
30793
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1959117
Quarters > 0 > balance Sheet > equity
9910141
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3218481
Quarters > 0 > cash Flow > depreciation
697
Quarters > 0 > cash Flow > change In Working Capital
1025161
Quarters > 0 > cash Flow > cash From Operations
-2174170
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-91616
Quarters > 0 > cash Flow > net Change In Cash
-2265786
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-104.3504522906332
Quarters > 0 > ratios > PB
0.0164368131492781
Quarters > 0 > ratios > ROE
-32.476641856054314
Quarters > 0 > ratios > ROA
-27.11610953271047
Quarters > 0 > ratios > FCF
-2174170
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
1101
Quarters > 1 > income Statement > gross Profit
-1101
Quarters > 1 > income Statement > operating Expenses
2408284
Quarters > 1 > income Statement > operating Income
-2409385
Quarters > 1 > income Statement > interest Expense
4185
Quarters > 1 > income Statement > pretax Income
-2374961
Quarters > 1 > income Statement > net Income
-2374961
Quarters > 1 > income Statement > eps
-77.00162111338066
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
30843
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2369675
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
34424
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
12129873
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
0
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
14137820
Quarters > 1 > balance Sheet > property Plant Equipment
3804
Quarters > 1 > balance Sheet > total Assets
14507875
Quarters > 1 > balance Sheet > payables
1261123
Quarters > 1 > balance Sheet > short Term Debt
121767
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1382890
Quarters > 1 > balance Sheet > equity
13124985
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2374961
Quarters > 1 > cash Flow > depreciation
1101
Quarters > 1 > cash Flow > change In Working Capital
-2991241
Quarters > 1 > cash Flow > cash From Operations
-5343260
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
4425541
Quarters > 1 > cash Flow > net Change In Cash
-917719
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-77.00162111338066
Quarters > 1 > ratios > PB
0.012410767395162737
Quarters > 1 > ratios > ROE
-18.094961632337103
Quarters > 1 > ratios > ROA
-16.370150694019628
Quarters > 1 > ratios > FCF
-5343260
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
3140
Quarters > 2 > income Statement > cost Of Revenue
1100
Quarters > 2 > income Statement > gross Profit
-1100
Quarters > 2 > income Statement > operating Expenses
4336560
Quarters > 2 > income Statement > operating Income
-4337660
Quarters > 2 > income Statement > interest Expense
6208
Quarters > 2 > income Statement > pretax Income
-4301320
Quarters > 2 > income Statement > net Income
-4301320
Quarters > 2 > income Statement > eps
-19.006318766294022
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
226310
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-4294012
Quarters > 2 > income Statement > operating Margin
-138142.03821656053
Quarters > 2 > income Statement > total Other Income Expense Net
36340
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
13047592
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
882539
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
13722026
Quarters > 2 > balance Sheet > property Plant Equipment
4905
Quarters > 2 > balance Sheet > total Assets
13749315
Quarters > 2 > balance Sheet > payables
2568520
Quarters > 2 > balance Sheet > short Term Debt
210673
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2779193
Quarters > 2 > balance Sheet > equity
10970122
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-4301320
Quarters > 2 > cash Flow > depreciation
1100
Quarters > 2 > cash Flow > change In Working Capital
995946
Quarters > 2 > cash Flow > cash From Operations
-3241907
Quarters > 2 > cash Flow > capital Expenditures
4188
Quarters > 2 > cash Flow > cash From Investing
-4188
Quarters > 2 > cash Flow > cash From Financing
9828121
Quarters > 2 > cash Flow > net Change In Cash
6586214
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-19.006318766294022
Quarters > 2 > ratios > PB
0.10895147775020186
Quarters > 2 > ratios > ROE
-39.20940897466774
Quarters > 2 > ratios > ROA
-31.28388577903699
Quarters > 2 > ratios > FCF
-3246095
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1033.7882165605095
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3140
Quarters > 3 > income Statement > cost Of Revenue
985
Quarters > 3 > income Statement > gross Profit
-985
Quarters > 3 > income Statement > operating Expenses
3199063
Quarters > 3 > income Statement > operating Income
-3200048
Quarters > 3 > income Statement > interest Expense
2774
Quarters > 3 > income Statement > pretax Income
-3176366
Quarters > 3 > income Statement > net Income
-3176366
Quarters > 3 > income Statement > eps
-1.7253369342513791
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1841012
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-3172607
Quarters > 3 > income Statement > operating Margin
-101912.3566878981
Quarters > 3 > income Statement > total Other Income Expense Net
23682
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6461378
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
882539
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
8658508
Quarters > 3 > balance Sheet > property Plant Equipment
6005
Quarters > 3 > balance Sheet > total Assets
8700943
Quarters > 3 > balance Sheet > payables
2198260
Quarters > 3 > balance Sheet > short Term Debt
326072
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2524332
Quarters > 3 > balance Sheet > equity
6176611
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-3176366
Quarters > 3 > cash Flow > depreciation
985
Quarters > 3 > cash Flow > change In Working Capital
-2425379
Quarters > 3 > cash Flow > cash From Operations
-5470859
Quarters > 3 > cash Flow > capital Expenditures
4188
Quarters > 3 > cash Flow > cash From Investing
-4188
Quarters > 3 > cash Flow > cash From Financing
4963301
Quarters > 3 > cash Flow > net Change In Cash
-511746
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.7253369342513791
Quarters > 3 > ratios > PB
1.5741539617113658
Quarters > 3 > ratios > ROE
-51.4257090174531
Quarters > 3 > ratios > ROA
-36.50599710858927
Quarters > 3 > ratios > FCF
-5475047
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1743.645541401274
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3306
Annuals > 0 > income Statement > gross Profit
-3306
Annuals > 0 > income Statement > operating Expenses
14898637
Annuals > 0 > income Statement > operating Income
-14901943
Annuals > 0 > income Statement > interest Expense
16119
Annuals > 0 > income Statement > pretax Income
-14857801
Annuals > 0 > income Statement > net Income
-14857801
Annuals > 0 > income Statement > eps
-46.83162390468386
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
317260
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-14838375
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
44142
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
6461378
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
882539
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
8658508
Annuals > 0 > balance Sheet > property Plant Equipment
6005
Annuals > 0 > balance Sheet > total Assets
8700943
Annuals > 0 > balance Sheet > payables
2198260
Annuals > 0 > balance Sheet > short Term Debt
326072
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2524332
Annuals > 0 > balance Sheet > equity
6176611
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-14857801
Annuals > 0 > cash Flow > depreciation
3306
Annuals > 0 > cash Flow > change In Working Capital
-3693874
Annuals > 0 > cash Flow > cash From Operations
-17113299
Annuals > 0 > cash Flow > capital Expenditures
4188
Annuals > 0 > cash Flow > cash From Investing
-4188
Annuals > 0 > cash Flow > cash From Financing
23030144
Annuals > 0 > cash Flow > net Change In Cash
5912657
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-46.83162390468386
Annuals > 0 > ratios > PB
0.2696648696186307
Annuals > 0 > ratios > ROE
-240.54940484352989
Annuals > 0 > ratios > ROA
-170.76081293717243
Annuals > 0 > ratios > FCF
-17117487
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
4134
Annuals > 1 > income Statement > gross Profit
-4134
Annuals > 1 > income Statement > operating Expenses
18860974
Annuals > 1 > income Statement > operating Income
-18865108
Annuals > 1 > income Statement > interest Expense
13805
Annuals > 1 > income Statement > pretax Income
-18851226
Annuals > 1 > income Statement > net Income
-18851226
Annuals > 1 > income Statement > eps
-3.0283093975903617
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
6225000
Annuals > 1 > income Statement > income Tax Expense
-4
Annuals > 1 > income Statement > EBITDA
-18860974
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
13882
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
548721
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1591170
Annuals > 1 > balance Sheet > property Plant Equipment
4933
Annuals > 1 > balance Sheet > total Assets
1700853
Annuals > 1 > balance Sheet > payables
5832162
Annuals > 1 > balance Sheet > short Term Debt
300806
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
6132968
Annuals > 1 > balance Sheet > equity
-4432115
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-18851226
Annuals > 1 > cash Flow > depreciation
4134
Annuals > 1 > cash Flow > change In Working Capital
3699146
Annuals > 1 > cash Flow > cash From Operations
-14140031
Annuals > 1 > cash Flow > capital Expenditures
3901
Annuals > 1 > cash Flow > cash From Investing
-3901
Annuals > 1 > cash Flow > cash From Financing
4637246
Annuals > 1 > cash Flow > net Change In Cash
-9506686
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-3.0283093975903617
Annuals > 1 > ratios > PB
-7.373736917927446
Annuals > 1 > ratios > ROE
425.3325105508318
Annuals > 1 > ratios > ROA
-1108.339521404848
Annuals > 1 > ratios > FCF
-14143932
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
11756
Annuals > 2 > income Statement > gross Profit
-11756
Annuals > 2 > income Statement > operating Expenses
14921213
Annuals > 2 > income Statement > operating Income
-14932969
Annuals > 2 > income Statement > interest Expense
7027
Annuals > 2 > income Statement > pretax Income
-15274134
Annuals > 2 > income Statement > net Income
-15274134
Annuals > 2 > income Statement > eps
-6.756956520777437
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2260505
Annuals > 2 > income Statement > income Tax Expense
7027
Annuals > 2 > income Statement > EBITDA
-15255351
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-341165
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
10055407
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
12564645
Annuals > 2 > balance Sheet > property Plant Equipment
5664
Annuals > 2 > balance Sheet > total Assets
13053115
Annuals > 2 > balance Sheet > payables
3681900
Annuals > 2 > balance Sheet > short Term Debt
409968
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
4920259
Annuals > 2 > balance Sheet > equity
8132856
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-15274134
Annuals > 2 > cash Flow > depreciation
11756
Annuals > 2 > cash Flow > change In Working Capital
3164348
Annuals > 2 > cash Flow > cash From Operations
-10557815
Annuals > 2 > cash Flow > capital Expenditures
4422
Annuals > 2 > cash Flow > cash From Investing
-4422
Annuals > 2 > cash Flow > cash From Financing
15613127
Annuals > 2 > cash Flow > net Change In Cash
5050890
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-6.756956520777437
Annuals > 2 > ratios > PB
1.459223088420599
Annuals > 2 > ratios > ROE
-187.8077516680487
Annuals > 2 > ratios > ROA
-117.01524118955513
Annuals > 2 > ratios > FCF
-10562237
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
13070
Annuals > 3 > income Statement > gross Profit
-13070
Annuals > 3 > income Statement > operating Expenses
14472845
Annuals > 3 > income Statement > operating Income
-14485915
Annuals > 3 > income Statement > interest Expense
9285
Annuals > 3 > income Statement > pretax Income
-14495200
Annuals > 3 > income Statement > net Income
-14495200
Annuals > 3 > income Statement > eps
-9.940290503467567
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1458227
Annuals > 3 > income Statement > income Tax Expense
9285
Annuals > 3 > income Statement > EBITDA
-14472845
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-9285
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
5004517
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
7477450
Annuals > 3 > balance Sheet > property Plant Equipment
16109
Annuals > 3 > balance Sheet > total Assets
8757385
Annuals > 3 > balance Sheet > payables
1522823
Annuals > 3 > balance Sheet > short Term Debt
387794
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2135566
Annuals > 3 > balance Sheet > equity
6621819
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-14495200
Annuals > 3 > cash Flow > depreciation
13070
Annuals > 3 > cash Flow > change In Working Capital
-780021
Annuals > 3 > cash Flow > cash From Operations
-13538309
Annuals > 3 > cash Flow > capital Expenditures
5748
Annuals > 3 > cash Flow > cash From Investing
-5748
Annuals > 3 > cash Flow > cash From Financing
4509081
Annuals > 3 > cash Flow > net Change In Cash
-9034976
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-9.940290503467567
Annuals > 3 > ratios > PB
1.1561312307086618
Annuals > 3 > ratios > ROE
-218.90057701667774
Annuals > 3 > ratios > ROA
-165.51972991937663
Annuals > 3 > ratios > FCF
-13544057
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
0.0068
Valuation > metrics > PB
0.0164368131492781
Valuation > final Score
90
Valuation > verdict
99.1% Undervalued
Profitability > metrics > ROE
-32.476641856054314
Profitability > metrics > ROA
-28.2527727339163
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.19768810554764055
Risk > metrics > Interest Coverage
-1537.5179584120983
Risk > final Score
-6090
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.814729288756108
Liquidity > metrics > Quick Ratio
5.814729288756108
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-2243
Prev Risks > 1
-2735
Prev Risks > 2
-4554
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:38:10.232Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-5.76
Earnings History > 0 > eps Estimate
-6.63
Earnings History > 0 > eps Difference
0.87
Earnings History > 0 > surprise Percent
13.1222
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-6.42
Earnings History > 1 > eps Estimate
-9.6
Earnings History > 1 > eps Difference
3.18
Earnings History > 1 > surprise Percent
33.125
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-2.2471
Earnings History > 2 > eps Estimate
-2
Earnings History > 2 > eps Difference
-0.2471
Earnings History > 2 > surprise Percent
-12.355
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-37.33
Earnings History > 3 > eps Estimate
-7.33
Earnings History > 3 > eps Difference
-30
Earnings History > 3 > surprise Percent
-409.2769
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.2527
Earnings History > 4 > eps Estimate
-0.1
Earnings History > 4 > eps Difference
-0.1527
Earnings History > 4 > surprise Percent
-152.7
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-6.7192
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.4068
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-14
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-28622.9609
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-2.7
Earnings History > 8 > eps Estimate
-2.4
Earnings History > 8 > eps Difference
-0.3
Earnings History > 8 > surprise Percent
-12.5
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-1.0371
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-2.5869
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-3.8211
Earnings History > 11 > eps Estimate
-2.4
Earnings History > 11 > eps Difference
-1.4211
Earnings History > 11 > surprise Percent
-59.2125
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-2.7
Earnings History > 12 > eps Estimate
-2.4
Earnings History > 12 > eps Difference
-0.3
Earnings History > 12 > surprise Percent
-12.5
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-2.7
Earnings History > 13 > eps Estimate
-2.4
Earnings History > 13 > eps Difference
-0.3
Earnings History > 13 > surprise Percent
-12.5
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-2.1
Earnings History > 14 > eps Estimate
-3.3
Earnings History > 14 > eps Difference
1.2
Earnings History > 14 > surprise Percent
36.3636
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-03
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-3
Earnings History > 15 > eps Estimate
-4.8
Earnings History > 15 > eps Difference
1.8
Earnings History > 15 > surprise Percent
37.5
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-4.2
Earnings History > 16 > eps Estimate
-4.87
Earnings History > 16 > eps Difference
0.67
Earnings History > 16 > surprise Percent
13.7577
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-4.5
Earnings History > 17 > eps Estimate
-3.9
Earnings History > 17 > eps Difference
-0.6
Earnings History > 17 > surprise Percent
-15.3846
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-4.5
Earnings History > 18 > eps Estimate
-3.6
Earnings History > 18 > eps Difference
-0.9
Earnings History > 18 > surprise Percent
-25
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-12
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-5.4
Earnings History > 19 > eps Estimate
-3.52
Earnings History > 19 > eps Difference
-1.88
Earnings History > 19 > surprise Percent
-53.4091
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-12
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-3.6
Earnings History > 20 > eps Estimate
-3.75
Earnings History > 20 > eps Difference
0.15
Earnings History > 20 > surprise Percent
4
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-10
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-4.5
Earnings History > 21 > eps Estimate
-2.4
Earnings History > 21 > eps Difference
-2.1
Earnings History > 21 > surprise Percent
-87.5
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-15
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-3.6
Earnings History > 22 > eps Estimate
-3
Earnings History > 22 > eps Difference
-0.6
Earnings History > 22 > surprise Percent
-20
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-12
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-5.1
Earnings History > 23 > eps Estimate
-0.9
Earnings History > 23 > eps Difference
-4.2
Earnings History > 23 > surprise Percent
-466.6667
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-12-20
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-1.5
Earnings History > 24 > eps Estimate
-0.9
Earnings History > 24 > eps Difference
-0.6
Earnings History > 24 > surprise Percent
-66.6667
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-28
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.03
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.03
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-06-28
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.02
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.02
Earnings History > 26 > surprise Percent
-
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACNS Pharmaceuticals (NASDAQ:CNSP) Stock Price Up 3.3% – What’s Next? Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$20
Analyst Picks
Strong Buy
1
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.86% of the total shares of CNS Pharmaceuticals Inc
1.
UBS Group AG(0.3478%)
since
2025/03/31
2.
Fidelity Extended Market Index(0.2311%)
since
2025/07/31
3.
Spartan Extended Market Index Pool F(0.1415%)
since
2025/07/31
4.
Tower Research Capital LLC(0.0741%)
since
2025/03/31
5.
Spartan Total Market Index Pool G(0.035%)
since
2025/07/31
6.
Fidelity Series Total Market Index(0.0242%)
since
2025/07/31
7.
BARRETT & COMPANY, INC.(0.0015%)
since
2025/06/30
8.
Mccormack Advisors International(0.0006%)
since
2025/03/31
9.
SBI Securities Co Ltd(0.0002%)
since
2025/06/30
10.
Bank of America Corp(0.0001%)
since
2025/03/31
11.
Goldman Sachs Group Inc(0%)
since
2025/03/31
12.
Connective Capital Management LLC(0%)
since
2025/03/31
13.
Ground Swell Capital, LLC(0%)
since
2025/06/30
14.
Integrated Wealth Concepts LLC(0%)
since
2025/03/31
15.
Jane Street Group LLC(0%)
since
2025/03/31
16.
Citadel Advisors Llc(0%)
since
2025/03/31
17.
Geode Capital Management, LLC(0%)
since
2025/03/31
18.
Synergy Investment Management, LLC(0%)
since
2025/03/31
19.
Two Sigma Investments LLC(0%)
since
2025/03/31
20.
Virtu Financial LLC(0%)
since
2025/03/31
21.
XTX Topco Ltd(0%)
since
2025/03/31
22.
HRT FINANCIAL LLC(0%)
since
2025/03/31
23.
NT Ext Eq Mkt Indx Fd DC Lend T3(0%)
since
2024/12/31
24.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-5.76
EPS Estimate
-6.63
EPS Difference
0.87
Surprise Percent
13.1222%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.